Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints

    ... BACKGROUND: Myelodysplastic syndromes (MDS) are a group of clonal neoplasms characterized by ...

    Research Article last updated 09/11/2017 - 8:59am.

  2. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... September 16, 2017 Myelodysplastic syndrome (MDS) with deletion 5q (del(5q)) is a distinct ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 10/02/2017 - 9:54am.

  3. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... June 22, 2017 Myelodysplastic syndrome (MDS) with deletion 5q (del(5q)) is a distinct ...

    Research Article last updated 10/23/2017 - 10:58am.

  4. Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/18/2017 - 2:37pm.

  5. Defeating anaemia in myelodysplastic syndromes: another step forward

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/18/2017 - 2:23pm.

  6. First-line Therapeutic Strategies for Myelodysplastic Syndromes.

    ... and subsequent prognostic stratification for patients with myelodysplastic syndrome (MDS) are often cumbersome, yet they are the basis of ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/11/2017 - 8:44am.

  7. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

    ... July 18, 2017 Myelodysplastic syndromes and chronic myelomonocytic leukemia are blood disorders ...

    Research Article last updated 08/03/2017 - 9:16am.

  8. HYPOMETHYLATING AGENTS (HMA) TREATMENT FOR MYELODYSPLASTIC SYNDROMES: ALTERNATIVES IN THE FRONTLINE AND RELAPSE SETTINGS

    ... agents (HMA) have played a pivotal role for treating myelodysplastic syndromes (MDS) over the past decade, inducing sustained hematological ...

    Research Article last updated 07/18/2017 - 1:15pm.

  9. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... haplo-HCT with PTCy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) at our institution from January 2009 to June ... acute myeloid leukemia (AML) myelodysplastic syndromes (MDS) ...

    Research Article last updated 11/14/2017 - 10:09am.

  10. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy

    ... patients with low- or intermediate 1-risk (lower risk) myelodysplastic syndromes (MDS) and thrombocytopenia , but its long-term toxicity ...

    Research Article last updated 07/11/2017 - 10:22am.